Stockreport

50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today [Yahoo! Finance]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF Relmada Therapeutics (RLMD) rose 61.1% to $7.17 on 92% response rate data, with $2.3B peak sales projection. Xenon's epilepsy drug and Relmada's bladder cancer treatme [Read more]